BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 22236848)

  • 1. Prevalence of positive tuberculosis skin tests during 5 years of screening in a Swiss remand prison.
    Ritter C; Elger BS
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):65-9. PubMed ID: 22236848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of latent tuberculosis infection in inmates recently incarcerated in a men's prison in Barcelona.
    Marco A; Solé N; Orcau A; Escribano M; del Baño L; Quintero S; Caylà JA
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):60-4. PubMed ID: 22236847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for tuberculosis on admission to highly endemic prisons? The case of Rio de Janeiro State prisons.
    Sanchez A; Larouzé B; Espinola AB; Pires J; Capone D; Gerhardt G; Cesconi V; Procopio MJ; Hijjar M; Massari V
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1247-52. PubMed ID: 19793429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chest radiographs and tuberculin skin tests in tuberculosis screening of internationally adopted children.
    George SA; Ko CA; Kirchner HL; Starke JR; Dragga TA; Mandalakas AM
    Pediatr Infect Dis J; 2011 May; 30(5):387-91. PubMed ID: 21076362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the QuantiFERON-TB Gold test to confirm latent tuberculosis infection in a Canadian tuberculosis clinic.
    Kunimoto D; Der E; Beckon A; Thomas L; Egedahl M; Beatch A; Williams G; Tyrrell G; Ahmed R; Brown N; Long R
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):726-30. PubMed ID: 19460248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
    Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
    Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
    BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy.
    Saracino A; Scotto G; Fornabaio C; Martinelli D; Faleo G; Cibelli D; Tartaglia A; Di Tullio R; Fazio V; Prato R; Monno L; Angarano G
    New Microbiol; 2009 Oct; 32(4):369-76. PubMed ID: 20128443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and incidence rates of latent tuberculous infection in a large prison in Iran.
    Mamani M; Mahmudian H; Majzoobi MM; Poorolajal J
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1072-7. PubMed ID: 27393542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence and risk factors associated with latent tuberculous infection in two Colombian prisons.
    Rueda ZV; Arroyave L; Marin D; López L; Keynan Y; Giraldo MR; Pulido H; Arbeláez MP
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1166-71. PubMed ID: 25216829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers.
    Harstad I; Winje BA; Heldal E; Oftung F; Jacobsen GW
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1209-11. PubMed ID: 20819271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of mass-screening on tuberculosis incidence in a prospective cohort of Brazilian prisoners.
    Paião DS; Lemos EF; Carbone AD; Sgarbi RV; Junior AL; da Silva FM; Brandão LM; Dos Santos LS; Martins VS; Simionatto S; Motta-Castro AR; Pompílio MA; Urrego J; Ko AI; Andrews JR; Croda J
    BMC Infect Dis; 2016 Oct; 16(1):533. PubMed ID: 27716170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results and significance of a baseline tuberculin skin test programme among health care workers in a hospital setting].
    Gerbaudo L; Violante B
    Med Lav; 2007; 98(3):221-31. PubMed ID: 17598350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-migration screening for active tuberculosis in Victoria, Australia.
    Flynn M; Brown L; Tesfai A; Lauer T
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):50-4. PubMed ID: 22236845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and risk factors associated with Mycobacterium tuberculosis infection in prisoners, North West Frontier Province, Pakistan.
    Hussain H; Akhtar S; Nanan D
    Int J Epidemiol; 2003 Oct; 32(5):794-9. PubMed ID: 14559752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].
    Sudre P; Rieder H; Bassetti S; Hirschel BJ; Ledergerber B; Malvy D
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2007-12. PubMed ID: 8984608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling tuberculosis in prisons against confinement conditions: a lost case? Experience from Cameroon.
    Noeske J; Ndi N; Mbondi S
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):223-7, i. PubMed ID: 21219685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
    Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
    Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of positive tuberculin skin tests in foreign-born children.
    Fortin K; Carceller A; Robert M; Chevalier I; Lamarre V; Lebel MH
    J Paediatr Child Health; 2007 Nov; 43(11):768-72. PubMed ID: 17803663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.
    Mazurek GH; Zajdowicz MJ; Hankinson AL; Costigan DJ; Toney SR; Rothel JS; Daniels LJ; Pascual FB; Shang N; Keep LW; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):826-36. PubMed ID: 17806046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.